Riverhead Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Riverhead Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$113K	Buy	13,600 +400	+3%	+$3.24K	﹤0.01%	1300
2019 Q2	$114K	Buy	13,200 +1,700	+15%	+$15.2K	﹤0.01%	1311
2019 Q1	$123K	Hold	11,500	–	–	0.01%	1279
2018 Q4	$101K	Buy	11,500 +2,000	+21%	+$25.5K	﹤0.01%	1301
2018 Q3	$160K	Buy	9,500 +800	+9%	+$17.3K	0.01%	1271
2018 Q2	$182K	Hold	8,700	–	–	0.01%	1137
2018 Q1	$140K	Buy	8,700 +900	+12%	+$17.8K	0.01%	1224
2017 Q4	$148K	Buy	7,800 +4,027	+107%	+$72.9K	0.01%	1202
2017 Q3	$53K	Buy	+3,773	New	+$34.1K	﹤0.01%	1435

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Riverhead Capital Management's SPPI Position: Q3 2019 in Review

Riverhead Capital Management increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 3% in Q3 2019, buying an estimated $3.24K and bringing the position to 13,600 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Riverhead Capital Management first reported a position in SPPI in Q3 2017 and has held it in 9 quarters since. The position peaked at $182K in Q2 2018. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Riverhead Capital Management held 13,600 shares of Spectrum Pharmaceuticals Inc worth $113K as of Q3 2019.
Riverhead Capital Management bought 400 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $3.24K.
Spectrum Pharmaceuticals Inc made up ﹤0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1300 holding.
Riverhead Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and has held it in 9 quarters since.
Riverhead Capital Management's Spectrum Pharmaceuticals Inc position peaked at $182K in Q2 2018.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.